PapersFlow Research Brief
Cardiac Ischemia and Reperfusion
Research Guide
What is Cardiac Ischemia and Reperfusion?
Cardiac ischemia and reperfusion refers to the pathological process where myocardial tissue experiences oxygen deprivation during ischemia followed by additional injury upon restoration of blood flow, involving mechanisms such as oxidative stress and mitochondrial permeability transition pore opening.
This field encompasses 59,509 papers on the pathophysiology, mechanisms, and therapeutic strategies related to myocardial reperfusion injury. Key areas include ischemic preconditioning, remote ischemic conditioning, oxidative stress, and cardioprotection in myocardial infarction. Central processes involve reactive oxygen species, cell signaling pathways, and the mitochondrial permeability transition pore.
Topic Hierarchy
Research Sub-Topics
Ischemic Preconditioning Mechanisms
This sub-topic investigates the molecular and cellular pathways triggered by brief ischemia-reperfusion cycles that confer cardioprotection against subsequent prolonged ischemia. Researchers study signaling cascades involving kinases, G-protein coupled receptors, and gene expression changes.
Remote Ischemic Conditioning
This sub-topic examines cardioprotective effects induced by transient ischemia in distant organs or limbs, focusing on humoral and neural signaling mediators. Researchers conduct clinical trials and preclinical studies on its efficacy in reducing reperfusion injury.
Mitochondrial Permeability Transition Pore
This sub-topic explores the role of the mPTP in mediating cell death during reperfusion through calcium overload and oxidative stress. Researchers identify inhibitors, structural components, and its regulation in ischemic contexts.
Oxidative Stress in Reperfusion Injury
This sub-topic analyzes reactive oxygen species generation sources, antioxidant defenses, and downstream damage in post-ischemic myocardium. Researchers develop biomarkers and evaluate antioxidants' therapeutic potential.
Myocardial Reperfusion Injury Therapies
This sub-topic evaluates pharmacological, ischemic, and device-based interventions to mitigate reperfusion damage in PCI and thrombolysis settings. Researchers perform meta-analyses and phase trials assessing clinical outcomes.
Why It Matters
Cardiac ischemia and reperfusion underlies lethal reperfusion injury in myocardial infarction, where restoring coronary blood flow paradoxically causes additional myocardial damage. Yellon and Hausenloy (2007) in "Myocardial Reperfusion Injury" detail mechanisms and cardioprotective strategies, noting that this injury contributes substantially to final infarct size in patients undergoing reperfusion therapies like percutaneous coronary intervention. Eltzschig and Eckle (2011) in "Ischemia and reperfusion—from mechanism to translation" bridge basic mechanisms to clinical translation, highlighting applications in reducing injury during heart surgery and stroke treatment. Murry et al. (1986) in "Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium" demonstrated that brief ischemic episodes precondition the heart, slowing ATP depletion and reducing cell death, a finding applied in protocols to limit infarction size.
Reading Guide
Where to Start
"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium" by Murry et al. (1986), as it introduces the foundational concept of ischemic preconditioning with direct experimental evidence on ATP preservation and cell survival in ischemic myocardium.
Key Papers Explained
Murry et al. (1986) in "Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium" established ischemic preconditioning as a protective mechanism against lethal injury. Yellon and Hausenloy (2007) in "Myocardial Reperfusion Injury" built on this by detailing reperfusion-specific mechanisms and cardioprotection strategies. Zorov et al. (2014) in "Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release" and Chouchani et al. (2014) in "Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS" advanced understanding of mitochondrial ROS and mPTP in reperfusion, linking to preconditioning effects. Eltzschig and Eckle (2011) in "Ischemia and reperfusion—from mechanism to translation" connects these to clinical applications.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes mitochondrial ROS mechanisms, with Chouchani et al. (2014) highlighting succinate-driven injury and Zorov et al. (2014) detailing ROS-induced ROS release via mPTP. Translation challenges persist, as noted by Eltzschig and Eckle (2011), focusing on why preconditioning efficacy varies clinically.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Heat Shock Protein A12B Protects Vascular Endothelial Cells Ag... | 2017 | Cellular Physiology an... | 10.7K | ✓ |
| 2 | Preconditioning with ischemia: a delay of lethal cell injury i... | 1986 | Circulation | 7.8K | ✓ |
| 3 | Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced RO... | 2014 | Physiological Reviews | 4.9K | ✓ |
| 4 | BCL-2 family members and the mitochondria in apoptosis | 1999 | Genes & Development | 3.6K | ✓ |
| 5 | Myocardial Reperfusion Injury | 2007 | New England Journal of... | 3.6K | ✕ |
| 6 | Ischemia and reperfusion—from mechanism to translation | 2011 | Nature Medicine | 3.2K | ✓ |
| 7 | A rapid and potent natriuretic response to intravenous injecti... | 1981 | Life Sciences | 3.1K | ✕ |
| 8 | Ischaemic accumulation of succinate controls reperfusion injur... | 2014 | Nature | 2.7K | ✓ |
| 9 | The mitochondrial generation of hydrogen peroxide. General pro... | 1973 | Biochemical Journal | 2.6K | ✓ |
| 10 | Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor ... | 1982 | New England Journal of... | 2.3K | ✕ |
Frequently Asked Questions
What is ischemic preconditioning?
Ischemic preconditioning involves brief episodes of ischemia that protect the myocardium against subsequent prolonged ischemia. Murry et al. (1986) in "Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium" showed that it slows ATP depletion and reduces lethal cell injury during ischemic episodes. Intermittent reperfusion during preconditioning washes out accumulated catabolites, enhancing myocardial protection.
How does the mitochondrial permeability transition pore contribute to reperfusion injury?
The mitochondrial permeability transition pore (mPTP) opening during reperfusion generates damaging reactive oxygen species and calcium overload. Zorov et al. (2014) in "Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release" explain that brief mPTP openings regulate ROS and Ca2+ homeostasis, but excessive activation leads to cell death. This process is central to myocardial reperfusion injury.
What role do reactive oxygen species play in cardiac ischemia-reperfusion?
Reactive oxygen species (ROS) produced by mitochondria during reperfusion exacerbate tissue damage through oxidative stress. Chouchani et al. (2014) in "Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS" demonstrated that succinate accumulation during ischemia drives ROS production upon reperfusion. Boveris and Chance (1973) in "The mitochondrial generation of hydrogen peroxide" quantified mitochondrial H2O2 production at up to 20 nmol/min per mg protein in heart mitochondria.
What are key cardioprotective strategies against reperfusion injury?
Strategies include ischemic preconditioning and targeting mPTP and ROS. Yellon and Hausenloy (2007) in "Myocardial Reperfusion Injury" review approaches to protect the heart during reperfusion in myocardial infarction. Eltzschig and Eckle (2011) in "Ischemia and reperfusion—from mechanism to translation" discuss translation of mechanisms like remote ischemic conditioning to clinical settings.
How does succinate influence reperfusion injury?
Succinate accumulates during ischemia and fuels reverse electron transport in mitochondria upon reperfusion, generating ROS. Chouchani et al. (2014) in "Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS" identified this pathway as a key controller of injury. Inhibiting succinate oxidation reduces ROS and protects the heart.
Open Research Questions
- ? How can mPTP inhibitors be optimized for clinical translation in human myocardial infarction?
- ? What are the precise signaling pathways linking succinate accumulation to ROS burst during reperfusion?
- ? Why does ischemic preconditioning fail to consistently protect in clinical settings despite robust preclinical data?
- ? How do BCL-2 family proteins modulate mitochondrial dynamics specifically in cardiac reperfusion injury?
- ? What role does intermittent reperfusion play in enhancing preconditioning beyond catabolite washout?
Recent Trends
The field maintains a large corpus of 59,509 papers, with sustained focus on mitochondrial mechanisms as evidenced by high citations to Zorov et al. at 4949 and Chouchani et al. (2014) at 2652.
2014Foundational works like Murry et al. with 7764 citations continue to anchor research on preconditioning.
1986No recent preprints or news in the last 12 months indicate steady rather than accelerating publication trends.
Research Cardiac Ischemia and Reperfusion with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cardiac Ischemia and Reperfusion with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers